Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Long Non-Coding RNA MALAT1 Is Necessary for Hematopoietic Stem and Progenitor Cell Expansion and Preleukemic Myeloproliferation in TET2 Deficient Myeloid Neoplasms

Nana Adjoa Ben-Crentsil, Ariel Quintana-Gonzalez, Maria E Balasis, Hannah Newman, Traci L. Kruer, Lei Sun, Christopher Letson, Abhishek Dhawan, Chetasi Talati, Meghan Ferrall-Fairbanks, Alexis Vedder, Kathy McGraw, Rami S. Komrokji, Li Ma, Eric Padron

Blood (2022) 140 (Supplement 1): 1991–1993.

https://doi.org/10.1182/blood-2022-156670

Published: 2022

Journal Articles

Immunohistochemical Analysis of Inflammasome Signaling Component Expression Among Patients with Low Risk and High Risk Myelodysplastic Syndrome Using Tissue Microarray

Tony J Kurian, Kathy McGraw, Sanjay Bridgelall, Rohit Sharma, Qianxing Mo, Wenyi Fan, Jeffrey E. Lancet, Rami S. Komrokji, Seongseok Yun, Ling Zhang

Blood (2021) 138 (Supplement 1): 4648.

https://doi.org/10.1182/blood-2021-150137

Published: 2021

Journal Articles

Tfeb Links MYC Signaling to Epigenetic Control of Acute Myeloid Leukemia Cell Death and Differentiation

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-137209

Published: 2020

Journal Articles

Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)

Blood (2019) 134 (Supplement_1): 676.

https://doi.org/10.1182/blood-2019-131055

Published: 2019

Journal Articles

Depletion of the Long Non-Coding RNA MALAT1 primes Chronic Myelomonocytic Leukemia (CMML) for Differentiation Therapy with All- Trans retinoic Acid (ATRA) through the Transcription Factor CREB

Blood (2019) 134 (Supplement_1): 1692.

https://doi.org/10.1182/blood-2019-128573

Published: 2019

Journal Articles

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

Grace A Ward, BS, Kathy McGraw, PhD, Amy F McLemore, M.S., Nghi B Lam, M.S., Hsin-An Hou, Benjamin S. Meyer, Alan F. List, MD

Blood (2019) 134 (Supplement_1): 774.

https://doi.org/10.1182/blood-2019-122358

Published: 2019

Journal Articles

Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Results of the E2905 Intergroup Phase III Study - an ECOG-ACRIN Cancer Research Group Study, Grant CA180820, and the National Cancer Institute of the National Institutes of Health

Alan F. List, MD, Zhuoxin Sun, PhD, Amit Verma, MBBS, John M. Bennett, MD, Kathy McGraw, PhD, Jaroslaw P. Maciejewski, MD PhD, Rami S. Komrokji, MD, Timothy R. Wassenaar, MD, Selina M. Luger, MD FRCPC, Ryan J. Mattison, MD, Puneet S. Cheema, MD, Jessica K. Altman, David F. Claxton, MD, Charles A. Schiffer, MD, Andrew S. Artz, MD, Mark Litzow, MD, Martin S. Tallman, MD

Blood (2019) 134 (Supplement_1): 842.

https://doi.org/10.1182/blood-2019-127274

Published: 2019

Journal Articles

Immune Checkpoint Profiling of TP53 Mutant and Wild-Type Myeloid Malignancies: TP53 Mutations Direct Immune Tolerance Via an Immunosuppressive Phenotype

David A Sallman, MD, McLemore Amy, Rami S. Komrokji, MD, Kathy McGraw, PhD, Susan M. Geyer, PhD, Erika Eksioglu, PhD MS, Najla Al Ali, M.Sc, Jeffrey E. Lancet, MD, Sheng Wei, MD, Eric Padron, MD, Alan F. List, MD

Blood (2017) 130 (Supplement 1): 423.

https://doi.org/10.1182/blood.V130.Suppl_1.423.423

Published: 2017

Journal Articles

The S100A9/Fto Axis Induces Formation of RNA:DNA Hybrids That Serve As Damps Initiating Myeloid Skewing & Genetic Injury in MDS

Erika Eksioglu, PhD MS, Xianghong Chen, PhD, Pingyan Cheng, MD, Jinhong Liu, MD, Kathy McGraw, PhD, David A Sallman, MD, Eric Padron, MD, Alan F List, MD, Sheng Wei, MD

Blood (2017) 130 (Supplement 1): 52.

https://doi.org/10.1182/blood.V130.Suppl_1.52.52

Published: 2017

Journal Articles

Molecular Predictors of Response in Patients with Myeloid Neoplasms Treated with Lenalidomide

Chantana Polprasert, MD, Tomas Radivoyevitch, PhD, Naoko Hosono, MD PhD, Hideki Makishima, MD PhD, Bartlomiej P Przychodzen, Brittney Dienes, Kathy McGraw, Sudipto Mukherjee, MD MPH, Hetty E. Carraway, MD, Mikkael A. Sekeres, MD MS, Alan F. List, MD, Jaroslaw P. Maciejewski, MD PhD

Blood (2014) 124 (21): 4665.

https://doi.org/10.1182/blood.V124.21.4665.4665

Published: 2014

Journal Articles

Novel Therapeutic Approach to Improve Hematopoiesis By Targeting Myeloid Derived Suppressor Cells with a Humanized Anti-CD33 Antibody

Erika A Eksioglu, PhD, Karl-Heinz Heider, PhD, Bjoern Rueter, MD, Alexis Burnette, Max Wei, Kathy McGraw, Ashley A Basiorka, Parthik Patel, Jeffrey Lancet, Rami Komrokji, MD, Alan F. List, MD, Sheng Wei, MD

Blood (2014) 124 (21): 4597.

https://doi.org/10.1182/blood.V124.21.4597.4597

Published: 2014

Journal Articles

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

Blood (2013) 122 (14): 2453–2459.

https://doi.org/10.1182/blood-2013-04-494930

Published: 2013

Includes: Supplemental data

Journal Articles

GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia

Eric Padron, Jeffrey S. Painter, Sateesh Kunigal, Adam W. Mailloux, Kathy McGraw, Jessica M. McDaniel, Eunhee Kim, Christopher Bebbington, Mark Baer, Geoffrey Yarranton, Jeffrey Lancet, Rami S. Komrokji, Omar Abdel-Wahab, Alan F. List, Pearlie K. Epling-Burnette

Blood (2013) 121 (25): 5068–5077.

https://doi.org/10.1182/blood-2012-10-460170

Published: 2013

Includes: Supplemental data

Journal Articles

STAT3-Mutations Indicate the Presence of Subclinical Self-Reactive Cytotoxic T Cell Clones in Aplastic Anemia and Myelodysplastic Syndromes

Blood (2012) 120 (21): 646.

https://doi.org/10.1182/blood.V120.21.646.646

Published: 2012

Journal Articles

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

Blood (2012) 120 (15): 3048–3057.

https://doi.org/10.1182/blood-2012-06-435297

Published: 2012

Includes: Supplemental data

Journal Articles

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

Blood (2012) 119 (25): 6109–6117.

https://doi.org/10.1182/blood-2011-12-397620

Published: 2012

Includes: Supplemental data

Journal Articles

Lenalidomide Upregulates Erythropoietin Receptor Expression in Hematopoietic Progenitors by Modulating Receptor Turnover

Ashley A Basiorka, Kathy McGraw, Justine Clark, MS, Gisela Caceres, Ph.D., Joe Johnson, Laura Hall, Lubomir Sokol, MD, PhD, Sheng Wei, MD, Alan F. List, MD

Blood (2011) 118 (21): 2382.

https://doi.org/10.1182/blood.V118.21.2382.2382

Published: 2011

Journal Articles

Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC)

Sheng Wei, MD, Xianghong Chen, Junmin Zhou, Ph.D, Ling Zhang, MD, Nicole R. Fortenbery, Sarah S Rasche, Ph.D, Kathy McGraw, Erika A. Eksioglu, Ph.D, P.K. Epling-Burnette, PhD, Julie Y. Djeu, Ph.D, Dmitry I. Gabrilovich, Ph.D, Alan F. List, MD

Blood (2011) 118 (21): 788.

https://doi.org/10.1182/blood.V118.21.788.788

Published: 2011

NARROW

The Long Non-Coding RNA MALAT1 Is Necessary for Hematopoietic Stem and Progenitor Cell Expansion and Preleukemic Myeloproliferation in TET2 Deficient Myeloid Neoplasms

Immunohistochemical Analysis of Inflammasome Signaling Component Expression Among Patients with Low Risk and High Risk Myelodysplastic Syndrome Using Tissue Microarray

Tfeb Links MYC Signaling to Epigenetic Control of Acute Myeloid Leukemia Cell Death and Differentiation

Phase 2 Results of APR-246 and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)

Depletion of the Long Non-Coding RNA MALAT1 primes Chronic Myelomonocytic Leukemia (CMML) for Differentiation Therapy with All- Trans retinoic Acid (ATRA) through the Transcription Factor CREB

Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes

Immune Checkpoint Profiling of TP53 Mutant and Wild-Type Myeloid Malignancies: TP53 Mutations Direct Immune Tolerance Via an Immunosuppressive Phenotype

The S100A9/Fto Axis Induces Formation of RNA:DNA Hybrids That Serve As Damps Initiating Myeloid Skewing & Genetic Injury in MDS

Molecular Predictors of Response in Patients with Myeloid Neoplasms Treated with Lenalidomide

Novel Therapeutic Approach to Improve Hematopoiesis By Targeting Myeloid Derived Suppressor Cells with a Humanized Anti-CD33 Antibody

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia

STAT3-Mutations Indicate the Presence of Subclinical Self-Reactive Cytotoxic T Cell Clones in Aplastic Anemia and Myelodysplastic Syndromes

STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis

Lenalidomide Upregulates Erythropoietin Receptor Expression in Hematopoietic Progenitors by Modulating Receptor Turnover

Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only